SANUWAVE Health (SNWV) Return on Capital Employed (2011 - 2026)
SANUWAVE Health's (SNWV) quarterly Return on Capital Employed came in at 17.02% in Q1 2026, up 4532.0% year-on-year from 0.37% in Q1 2025, and down 35.89% on a QoQ basis from 26.55% in Q4 2025.
SANUWAVE Health (SNWV) Return on Capital Employed (2011 - 2026) Analysis & Trends
SANUWAVE Health (SNWV) has 16 years of Return on Capital Employed data on file, last reported at 17.02% in Q1 2026.
- On a quarterly basis, Return on Capital Employed rose 4532.0% year-over-year to 17.02% in Q1 2026; TTM through Mar 2026 was 17.02%, a 4532.0% increase from a year earlier, with the FY2025 full-year figure at 31.13%, up 5122.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 17.02%, down from 26.55% in the prior quarter.
- Over the last five years, Return on Capital Employed for SNWV reached as high as 47.92% in Q3 2025 and fell as low as 29.97% in Q2 2025.
- Historically, Return on Capital Employed has averaged 8.85% across 5 years, with a median of 8.2% in 2023.
- Across the five-year window, Return on Capital Employed sank 6636 bps in 2022 and soared 5271 bps in 2025, its largest moves.
- Year by year, Return on Capital Employed stood at 21.89% in 2022, then tumbled by 94 bps to 1.24% in 2023, then plunged by 1693 bps to 19.79% in 2024, then jumped by 234 bps to 26.55% in 2025, then tumbled by 36 bps to 17.02% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 17.02% in Q1 2026, 26.55% in Q4 2025, and 47.92% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | SANUWAVE Health | 18.65 Mn | 7.87 Mn | 7.43 Mn | 17.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.02% |
| Dec 31, 2025 | 26.55% |
| Sep 30, 2025 | 47.92% |
| Jun 30, 2025 | -29.97% |
| Mar 31, 2025 | -28.30% |
| Dec 31, 2024 | -19.79% |
| Sep 30, 2024 | -4.78% |
| Jun 30, 2024 | -2.28% |
| Mar 31, 2024 | -0.31% |
| Dec 31, 2023 | 1.24% |
| Sep 30, 2023 | 4.63% |
| Jun 30, 2023 | 8.20% |
| Mar 31, 2023 | 17.27% |
| Dec 31, 2022 | 21.89% |
| Sep 30, 2022 | 27.93% |
| Jun 30, 2022 | 30.74% |
| Mar 31, 2022 | 32.43% |
| Dec 31, 2021 | 37.85% |
| Sep 30, 2021 | 40.61% |
| Jun 30, 2021 | 60.97% |